Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuroradiolological Analysis of COVID-19 Patients (COVID-19BRAIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04368390
Recruitment Status : Recruiting
First Posted : April 29, 2020
Last Update Posted : April 29, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France

Brief Summary:
To describe the radiological presentation of brain abnormalities in COVID-19 + patients

Condition or disease
Covid-19

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Other
Official Title: Imaging Analysis of COVID-19 + Patients With Abnormal Neurological Examination
Actual Study Start Date : April 3, 2020
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : April 2021



Primary Outcome Measures :
  1. Neuroradiological analysis of patients brain MRI [ Time Frame: 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients COVID-19 with abnormal neurological examination
Criteria

Inclusion Criteria:

  • Adults
  • COVID-19 +
  • Abnormal neurological examination
  • who underwent a brain MRI

Exclusion Criteria:

  • No participation agreement
  • Non COVID-19 patients
  • Patients COVID-19 + without neurological abnormality or without MRI examination

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04368390


Contacts
Layout table for location contacts
Contact: Stephane Kremer, MD, PhD 33 3 88 12 78 89 stephane.kremer@chru-strasbourg.fr
Contact: Saïd CHAYER, PhD, HDR 33 3 88 11 66 90 said.chayer@chru-strasbourg.fr

Locations
Layout table for location information
France
Service d'Imagerie 2 - Neuroradiologie Recruiting
Strasbourg, France, 67091
Contact: Stéphane KREMER, MD, PhD    33 3 88 12 78 89    stephane.kremer@chru-strasbourg.fr   
Contact: Saïd CHAYER, PhD, HDR    33 3 88 11 66 90    said.chayer@chru-strasbourg.fr   
Principal Investigator: Stéphane KREMER, MD, PhD         
Sponsors and Collaborators
University Hospital, Strasbourg, France
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier: NCT04368390    
Other Study ID Numbers: 7759
First Posted: April 29, 2020    Key Record Dates
Last Update Posted: April 29, 2020
Last Verified: April 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by University Hospital, Strasbourg, France:
COVID-19
MRI
Brain